Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Baseimmune Logo
Baseimmune Growth Score
51
CB Rank
45662
Heat Score
30
Baseimmune is a biotech startup founded to create the next generation of vaccines.
Founded
obfuscation
PrivateSeries A London, England, United Kingdom11-50 www.baseimmune.co.uk/
Biotechnology
Health Care
Life Science
Overview

Baseimmune
Total Funding
obfuscation
Growth Score
51
Heat Score
30

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score51
-1 pts
in past quarter
Heat Score 30
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Baseimmune

CB Rank
45662
Baseimmune is a biotech startup founded to create the next generation of vaccines.
Founded
obfuscation
PrivateSeries A London, England, United Kingdom11-50 www.baseimmune.co.uk/
Biotechnology
Health Care
Life Science

Funding Rounds

Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Baseimmune Ltd
Operating Status Active
Company Type For Profit
Founders  Ariane Gomes, Joshua Blight, Phillip Kemlo
About the Company
Baseimmune is a biotech startup founded to create the next generation of vaccines.
Contact Email info@baseimmune.co.uk
Predictions & Insights

Growth Insight

See this Growth Insight
Baseimmune is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Vaccine Design Algorithm
A computational platform that integrates genomic, epidemiological, immunological, clinical, and evolutionary data to create synthetic antigens for vaccines.
African Swine Fever Vaccine
A preclinical vaccine candidate designed to protect against various strains of the African Swine Fever virus.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A
obfuscation
Series A - Baseimmune Logo
Series A - Baseimmune
6
obfuscation
IQ Capital, Merck Global Health Innovation FundSeries A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Maki.vc Logo
Maki.vc
—
Series A - Baseimmune Logo
Series A - Baseimmune
—
Maki.vc Logo
Maki.vc
—
Series A - Baseimmune Logo
Series A - Baseimmune
—
Maki.vc Logo
Maki.vc
—
Series A - Baseimmune Logo
Series A - Baseimmune
—
Maki.vc Logo
Maki.vc
—
Series A - Baseimmune Logo
Series A - Baseimmune
—
Maki.vc Logo
Maki.vc
—
Series A - Baseimmune Logo
Series A - Baseimmune
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Board Members and Advisors 1 Contacts 7

Employee Profiles

Board Members and Advisors

News

News and Press

News•Aug 22, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

118
-90.6%
 in past month

IT Spend

$230.3KThis year, Baseimmune is projected to spend $230.3K on IT, according to Aberdeen.

Active Website Tech Count

20Baseimmune is actively using 20 technologies for its website, according to BuiltWith. These include Viewport Meta, SSL by Default, and  Apple Mobile Web Clips Icon.

Total IP

2Baseimmune has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Baseimmune has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Baseimmune's headquarters? Baseimmune is located in London, England, United Kingdom.Who invested in Baseimmune? Baseimmune has 9 investors including Maki.vc and  Creator Fund.When was the last funding round for Baseimmune? Baseimmune closed its last funding round on
obfuscation
from a Series A round.Who are Baseimmune's competitors? Alternatives and possible competitors to Baseimmune may include Serum Institute of India Pvt. Ltd., Valneva, and  Novavax.How much funding has Baseimmune raised to date? Baseimmune has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|